What type of study is this?

October 3, 2025

Clinical Effects of Lactobacillus reuteri on Gingival Inflammation and Alveolar Bone Loss in Periodontitis.

View Full Paper

Ask AI

Bookmark

Lactobacillus reuteri significantly reduces alveolar bone loss and inflammatory markers in periodontitis patients, showing clinical improvement.
Primary outcome measures demonstrate significant reductions in TNF-α and IL-6 levels after treatment with Lactobacillus reuteri.
The randomized, double-blind, placebo-controlled trial supports Lactobacillus reuteri's role in modulating endoplasmic reticulum stress related to periodontitis.
These findings suggest Lactobacillus reuteri may serve as an adjunctive therapy in the management of periodontal disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial shows Lactobacillus reuteri reduces gingival inflammation and alveolar bone loss in periodontitis, indicating its therapeutic potential.

Cite This Study

Lu et al. (2025) studied this question.

synapsesocial.com/papers/68e02f34f0e39f13e7fa206d https://doi.org/10.3290/j.ohpd.c_2289

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial shows Lactobacillus reuteri reduces gingival inflammation and alveolar bone loss in periodontitis, indicating its therapeutic potential.

Clinical Effects of Lactobacillus reuteri on Gingival Inflammation and Alveolar Bone Loss in Periodontitis.

Key Points

Discussion

Implication

Cite This Study

Clinical Effects of Lactobacillus reuteri on Gingival Inflammation and Alveolar Bone Loss in Periodontitis.

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider